Código 293329 (Harmonized System 2012 by 6 digits)
2024: US$32.1M, Total Trade Exchange
2024: US$6.81M, International Sales
2024: US$25.3M, International Purchases
In 2024, the trade exchange (includes international purchases and sales) of Heterocyclic Compounds with Nitrogen Hetero [S] only with Imidazole Cycle, even Hydrogenated, in Structure (No Hydantoin and its Derivatives, and Products of Subheading 3002 10) was US$32.1M.
In 2024, the states with the most international sales in Heterocyclic Compounds with Nitrogen Hetero [S] only with Imidazole Cycle, even Hydrogenated, in Structure (No Hydantoin and its Derivatives, and Products of Subheading 3002 10) were Estado de México (US$6.59M), Ciudad de México (US$43.5k), and Querétaro (US$14.2k).
The states with the most international purchases in 2024 were Jalisco (US$8.69M), Ciudad de México (US$7.59M), Estado de México (US$7.35M), Querétaro (US$692k), and Nuevo León (US$445k).
In 2024, the main commercial destinations of Heterocyclic Compounds with Nitrogen Hetero [S] only with Imidazole Cycle, even Hydrogenated, in Structure (No Hydantoin and its Derivatives, and Products of Subheading 3002 10) were United States (US$2.64M), India (US$2.45M), Australia (US$832k), South Korea (US$336k), and Colombia (US$150k).
The main commercial origins of Heterocyclic Compounds with Nitrogen Hetero [S] only with Imidazole Cycle, even Hydrogenated, in Structure (No Hydantoin and its Derivatives, and Products of Subheading 3002 10) in 2024 were China (US$10.2M), Italy (US$3.81M), India (US$3.4M), France (US$2.14M), and Spain (US$1.68M).
In the global context, the main exporting countries of Heterocyclic Compounds with Nitrogen Hetero [S] only with Imidazole Cycle, even Hydrogenated, in Structure (No Hydantoin and its Derivatives, and Products of Subheading 3002 10) in 2022 were China (US$585M), France (US$404M), and India (US$318M). In the same year, the main importing countries of Heterocyclic Compounds with Nitrogen Hetero [S] only with Imidazole Cycle, even Hydrogenated, in Structure (No Hydantoin and its Derivatives, and Products of Subheading 3002 10) were United Kingdom (US$280M), United States (US$156M), and Japan (US$140M).
US$32.1M, Total Trade Exchange (2024)
In 2024, the total trade exchange of Heterocyclic Compounds with Nitrogen Hetero [S] only with Imidazole Cycle, even Hydrogenated, in Structure (No Hydantoin and its Derivatives, and Products of Subheading 3002 10) in Mexico (including international purchases and sales) was US$32.1M.
The visualizations show the net balance of Heterocyclic Compounds with Nitrogen Hetero [S] only with Imidazole Cycle, even Hydrogenated, in Structure (No Hydantoin and its Derivatives, and Products of Subheading 3002 10) at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
March, 2025
In March 2025, international sales of Heterocyclic Compounds with Nitrogen Hetero [S] only with Imidazole Cycle, even Hydrogenated, in Structure (No Hydantoin and its Derivatives, and Products of Subheading 3002 10) were US$435k, while international purchases reached US$3.19M. The above results in a trade balance of -US$2.75M.
2025-Q1: US$184k, International Sales
The visualization shows the quarterly concentration of international sales of Heterocyclic Compounds with Nitrogen Hetero [S] only with Imidazole Cycle, even Hydrogenated, in Structure (No Hydantoin and its Derivatives, and Products of Subheading 3002 10) at state level.
In the first quarter of 2025, international sales were US$184k, being the states with the most sales Estado de México (US$184k).
Estado de México: US$6.59M, State with the Most International Sales (2024)
United States: US$2.64M, Main commercial destination (2024)
In 2024, the states with the highest international sales in Heterocyclic Compounds with Nitrogen Hetero [S] only with Imidazole Cycle, even Hydrogenated, in Structure (No Hydantoin and its Derivatives, and Products of Subheading 3002 10) were Estado de México (US$6.59M), Ciudad de México (US$43.5k), and Querétaro (US$14.2k).
In 2024, the countries with the most international purchases from Mexico were United States (US$2.64M), India (US$2.45M), Australia (US$832k), South Korea (US$336k), and Colombia (US$150k).
Jalisco: US$8.69M, State with the Most International Purchases (2024)
China: US$10.2M, Main Commercial Origin (2024)
In 2024, the states with the highest international in Heterocyclic Compounds with Nitrogen Hetero [S] only with Imidazole Cycle, even Hydrogenated, in Structure (No Hydantoin and its Derivatives, and Products of Subheading 3002 10) were Jalisco (US$8.69M), Ciudad de México (US$7.59M), Estado de México (US$7.35M), Querétaro (US$692k), and Nuevo León (US$445k).
The countries with the most international sales to Mexico in 2024 were China (US$10.2M), Italy (US$3.81M), India (US$3.4M), France (US$2.14M), and Spain (US$1.68M).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Heterocyclic Compounds with Nitrogen Hetero [S] only with Imidazole Cycle, even Hydrogenated, in Structure (No Hydantoin and its Derivatives, and Products of Subheading 3002 10) and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Heterocyclic Compounds with Nitrogen Hetero [S] only with Imidazole Cycle, even Hydrogenated, in Structure (No Hydantoin and its Derivatives, and Products of Subheading 3002 10). On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Heterocyclic Compounds with Nitrogen Hetero [S] only with Imidazole Cycle, even Hydrogenated, in Structure (No Hydantoin and its Derivatives, and Products of Subheading 3002 10). In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Heterocyclic Compounds with Nitrogen Hetero [S] only with Imidazole Cycle, even Hydrogenated, in Structure (No Hydantoin and its Derivatives, and Products of Subheading 3002 10) were China (US$585M), France (US$404M), and India (US$318M). In the same year, the main importing countries for Heterocyclic Compounds with Nitrogen Hetero [S] only with Imidazole Cycle, even Hydrogenated, in Structure (No Hydantoin and its Derivatives, and Products of Subheading 3002 10) were United Kingdom (US$280M), United States (US$156M), and Japan (US$140M).